These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32343715)

  • 21. Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.
    Oka M; Otani M; Miyamoto Y; Oshima R; Adachi J; Tomonaga T; Asally M; Nagaoka Y; Tanaka K; Toyoda A; Ichikawa K; Morishita S; Isono K; Koseki H; Nakato R; Ohkawa Y; Yoneda Y
    Cell Rep; 2023 Aug; 42(8):112884. PubMed ID: 37516964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mobile FG nucleoporin Nup98 is a cofactor for Crm1-dependent protein export.
    Oka M; Asally M; Yasuda Y; Ogawa Y; Tachibana T; Yoneda Y
    Mol Biol Cell; 2010 Jun; 21(11):1885-96. PubMed ID: 20375145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
    Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
    Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; van Grotel M; Tchinda J; Lee C; Beverloo HB; van der Spek PJ; Stubbs A; Cools J; Nagata K; Fornerod M; Buijs-Gladdines J; Horstmann M; van Wering ER; Soulier J; Pieters R; Meijerink JP
    Blood; 2008 May; 111(9):4668-80. PubMed ID: 18299449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.
    Oka M; Mura S; Yamada K; Sangel P; Hirata S; Maehara K; Kawakami K; Tachibana T; Ohkawa Y; Kimura H; Yoneda Y
    Elife; 2016 Jan; 5():e09540. PubMed ID: 26740045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nucleoporin-like protein NLP1 (hCG1) promotes CRM1-dependent nuclear protein export.
    Waldmann I; Spillner C; Kehlenbach RH
    J Cell Sci; 2012 Jan; 125(Pt 1):144-54. PubMed ID: 22250199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
    Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
    Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated nuclear protein export.
    Bernad R; van der Velde H; Fornerod M; Pickersgill H
    Mol Cell Biol; 2004 Mar; 24(6):2373-84. PubMed ID: 14993277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleoporins and nucleocytoplasmic transport in hematologic malignancies.
    Takeda A; Yaseen NR
    Semin Cancer Biol; 2014 Aug; 27():3-10. PubMed ID: 24657637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.
    Mendes A; Jühlen R; Bousbata S; Fahrenkrog B
    Cells; 2020 Jul; 9(7):. PubMed ID: 32664447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
    Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
    Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions.
    Yung E; Sekulovic S; Argiropoulos B; Lai CK; Leung M; Berg T; Vollett S; Chang VC; Wan A; Wong S; Humphries RK
    Leuk Res; 2011 Apr; 35(4):545-50. PubMed ID: 21130494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.
    Nguyen AT; Taranova O; He J; Zhang Y
    Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
    Quentmeier H; Schneider B; Röhrs S; Romani J; Zaborski M; Macleod RA; Drexler HG
    J Hematol Oncol; 2009 Jan; 2():3. PubMed ID: 19166587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.
    Gough SM; Lee F; Yang F; Walker RL; Zhu YJ; Pineda M; Onozawa M; Chung YJ; Bilke S; Wagner EK; Denu JM; Ning Y; Xu B; Wang GG; Meltzer PS; Aplan PD
    Cancer Discov; 2014 May; 4(5):564-77. PubMed ID: 24535671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
    Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
    Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemia-Associated Nup214 Fusion Proteins Disturb the XPO1-Mediated Nuclear-Cytoplasmic Transport Pathway and Thereby the NF-κB Signaling Pathway.
    Saito S; Cigdem S; Okuwaki M; Nagata K
    Mol Cell Biol; 2016 Jul; 36(13):1820-35. PubMed ID: 27114368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.
    Nakamura T
    Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo analysis of human nucleoporin repeat domain interactions.
    Xu S; Powers MA
    Mol Biol Cell; 2013 Apr; 24(8):1222-31. PubMed ID: 23427268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.